AngioDynamics, Inc. vs. Baxter International Inc.
Baxter International Inc. (BAX) comes out ahead, leading on 7 of 8 compared factors.
Size & Scale
| ANGO | BAX | |
|---|---|---|
| Market Cap | $635.28 million | $11.90 billion |
| Revenue (TTM) | $320.17 million | $11.47 billion |
| Net Income (TTM) | $-36,742,000 | $-1,063,000,000 |
BAX leads on 2 of 3 size & scale factors.
Valuation
| ANGO | BAX | |
|---|---|---|
| Price / Book | 3.72 | 1.93 |
| Price / Sales | 1.98 | 1.04 |
BAX leads on 2 of 2 valuation factors.
Profitability
| ANGO | BAX | |
|---|---|---|
| Net Margin | -11.48% | -9.27% |
| Return on Equity | -21.51% | -17.20% |
BAX leads on 2 of 2 profitability factors.
Dividend
| ANGO | BAX | |
|---|---|---|
| Dividend Yield | — | 0.18% |
ANGO and BAX split the dividend factors evenly.
Risk & Sentiment
| ANGO | BAX | |
|---|---|---|
| Short Interest | 4.46% | 1.03% |
BAX leads on 1 of 1 risk & sentiment factors.
Dig deeper: ANGO overview, ANGO financials, BAX overview, BAX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.